Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 239

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

De novo design of high-affinity binders of bioactive helical peptides

Open access
Vázquez Torres, Susana, Leung, Philip J. Y., Venkatesh, Preetham, Lutz, Isaac D., Hink, Fabian, Huynh, Huu-Hien, Becker, Jessica, Yeh, Andy Hsien-Wei, Juergens, David, Bennett, Nathaniel R., Hoofnagle, Andrew N., Huang, Eric, MacCoss, Michael J., Expòsit, Marc, Lee, Gyu Rie, Bera, Asim K., Kang, Alex, De La Cruz, Joshmyn, Levine, Paul M., Li, Xinting, Lamb, Mila, Gerben, Stacey R., Murray, Analisa, Heine, Piper, Korkmaz, Elif Nihal, Nivala, Jeff, Stewart, Lance, Watson, Joseph L., Rogers, Joseph M., Baker, David·2024·Nature

Abstract

Many peptide hormones form an α-helix on binding their receptors 1–4, and sensitive methods for their detection could contribute to better clinical management of disease 5. De novo protein design can now generate binders with high affinity and specificity to structured proteins 6,7. However, the design of interactions between proteins and short peptides with helical propensity is an unmet challenge. Here we describe parametric generation and deep learning-based methods for designing proteins to address this challenge. We show that by extending RFdiffusion 8 to enable binder design to flexible targets, and to refining input structure models by successive noising and denoising (partial diffusion), picomolar-affinity binders can be generated to helical peptide targets by either refining designs generated with other methods, or completely de novo starting from random noise distributions without any subsequent experimental optimization. The RFdiffusion designs enable the enrichment and subsequent detection of parathyroid hormone and glucagon by mass spectrometry, and the construction of bioluminescence-based protein biosensors. The ability to design binders to conformationally variable targets, and to optimize by partial diffusion both natural and designed proteins, should be broadly useful.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06953-1

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 46

  1. Pioszak, A. A. & Xu, H. E. Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc. Natl Acad. Sci. USA 105, 5034–5039 (2008). · DOI · Paper page
  2. Park, C. et al. Structural basis of neuropeptide Y signaling through Y1 receptor. Nat. Commun. 13, 853 (2022). · DOI
  3. Sasaki, K., Dockerill, S., Adamiak, D. A., Tickle, I. J. & Blundell, T. X-ray analysis of glucagon and its relationship to receptor binding. Nature 257, 751–757 (1975). · DOI · Paper page
  4. Fukuhara, S. et al. Structure of the human secretin receptor coupled to an engineered heterotrimeric G protein. Biochem. Biophys. Res. Commun. 533, 861–866 (2020). · DOI
  5. Wewer Albrechtsen, N. J., Kuhre, R. E., Pedersen, J., Knop, F. K. & Holst, J. J. The biology of glucagon and the consequences of hyperglucagonemia. Biomark. Med. 10, 1141–1151 (2016). · DOI
  6. Bennett, N. R. et al. Improving de novo protein binder design with deep learning. Nat. Commun. 14, 2625 (2023). · DOI · Paper page
  7. Cao, L. et al. Design of protein-binding proteins from the target structure alone. Nature 605, 551–560 (2022). · DOI · Paper page
  8. Hocher, B. et al. Measuring parathyroid hormone (PTH) in patients with oxidative stress-do we need a fourth generation parathyroid hormone assay? PLoS ONE 7, e40242 (2012). · doi:10.1371/journal.pone.0040242
  9. Saper, C. B. A guide to the perplexed on the specificity of antibodies. J. Histochem. Cytochem. 57, 1–5 (2009). · DOI · Paper page
  10. Le Basle, Y., Chennell, P., Tokhadze, N., Astier, A. & Sautou, V. Physicochemical stability of monoclonal antibodies: a review. J. Pharm. Sci. 109, 169–190 (2020). · DOI · Paper page
  11. Lee, J. H., Yin, R., Ofek, G. & Pierce, B. G. Structural features of antibody-peptide recognition. Front. Immunol. 13, 910367 (2022). · DOI
  12. Ghirlanda, G., Lear, J. D., Lombardi, A. & DeGrado, W. F. From synthetic coiled coils to functional proteins: automated design of a receptor for the calmodulin-binding domain of calcineurin. J. Mol. Biol. 281, 379–391 (1998). · DOI
  13. Wright, P. E. & Dyson, H. J. Linking folding and binding. Curr. Opin. Struct. Biol. 19, 31–38 (2009). · DOI · Paper page
  14. Lazar, T., Tantos, A., Tompa, P. & Schad, E. Intrinsic protein disorder uncouples affinity from binding specificity. Protein Sci. 31, e4455 (2022). · DOI
  15. Gisdon, F. J. et al. Modular peptide binders - development of a predictive technology as alternative for reagent antibodies. Biol. Chem. 403, 535–543 (2022). · DOI
  16. Wu, K. et al. De novo design of modular peptide-binding proteins by superhelical matching. Nature 616, 581–589 (2023). · DOI
  17. Grigoryan, G. & Degrado, W. F. Probing designability via a generalized model of helical bundle geometry. J. Mol. Biol. 405, 1079–1100 (2011). · DOI · Paper page
  18. Kobayashi, K. et al. Endogenous ligand recognition and structural transition of a human PTH receptor. Mol. Cell 82, 3468–3483 (2022). · DOI
  19. Yin, H. et al. Computational design of peptides that target transmembrane helices. Science 315, 1817–1822 (2007). · DOI · Paper page
  20. Praetorius, F. et al. Design of stimulus-responsive two-state hinge proteins. Science 381, 754–760 (2023). · DOI · Paper page
  21. Hall, C. M., Glaser, S. & Alpini, G. in Reference Module in Neuroscience and Biobehavioral Psychology (ed. Stein, J.) (Elsevier, 2017).
  22. Wicky, B. I. M. et al. Hallucinating symmetric protein assemblies. Science 378, 56–61 (2022). · DOI · Paper page
  23. Liu, Q. et al. Apoptotic regulation by MCL-1 through heterodimerization. J. Biol. Chem. 285, 19615–19624 (2010). · DOI
  24. Crabtree, M. D., Mendonça, C. A. T. F., Bubb, Q. R. & Clarke, J. Folding and binding pathways of BH3-only proteins are encoded within their intrinsically disordered sequence, not templated by partner proteins. J. Biol. Chem. 293, 9718–9723 (2018). · DOI
  25. Khatib, F. et al. Algorithm discovery by protein folding game players. Proc. Natl Acad. Sci. USA 108, 18949–18953 (2011). · DOI · Paper page
  26. Kühlmann, U. C., Pommer, A. J., Moore, G. R., James, R. & Kleanthous, C. Specificity in protein-protein interactions: the structural basis for dual recognition in endonuclease colicin-immunity protein complexes. J. Mol. Biol. 301, 1163–1178 (2000). · DOI
  27. Larhammar, D. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul. Pept. 62, 1–11 (1996). · DOI · Paper page
  28. Kang, H. et al. Structural basis for Y2 receptor-mediated neuropeptide Y and peptide YY signaling. Structure 31, 44–57 (2023). · DOI
  29. Säll, A. et al. Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range. PLoS ONE 13, e0189116 (2018). · DOI
  30. Shi, J. et al. A distributable LC-MS/MS method for the measurement of serum thyroglobulin. J. Mass Spectrom. Adv. Clin. Lab 26, 28–33 (2022). · DOI
  31. Zhou, H. et al. Generation of monoclonal antibodies against highly conserved antigens. PLoS ONE 4, e6087 (2009). · DOI
  32. Rajan, S., Choi, M., Baek, K. & Yoon, H. S. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis. Proteins 83, 1262–1272 (2015). · DOI
  33. Lee, E. F. et al. High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL. Angew. Chem. Int. Ed. Engl. 48, 4318–4322 (2009). · DOI · Paper page
  34. Parthier, C. et al. Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc. Natl Acad. Sci. USA 104, 13942–13947 (2007). · DOI · Paper page
  35. Dong, M. et al. Structure and dynamics of the active Gs-coupled human secretin receptor. Nat. Commun. 11, 4137 (2020). · DOI
  36. Zhang, X. et al. Differential GLP-1R binding and activation by peptide and non-peptide agonists. Mol. Cell 80, 485–500 (2020). · DOI · Paper page
  37. Jin, L. et al. Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution. J. Biol. Chem. 275, 27238–27244 (2000). · DOI
  38. Nygaard, R., Nielbo, S., Schwartz, T. W. & Poulsen, F. M. The PP-fold solution structure of human polypeptide YY and human PYY3-36 as determined by NMR. Biochemistry 45, 8350–8357 (2006). · DOI
  39. Tang, T. et al. Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors. Sci. Adv. 8, eabm1232 (2022). · DOI
  40. Brunette, T. J. et al. Exploring the repeat protein universe through computational protein design. Nature 528, 580–584 (2015). · DOI · Paper page
  41. Leman, J. K. et al. Macromolecular modeling and design in Rosetta: recent methods and frameworks. Nat. Methods 17, 665–680 (2020). · DOI · Paper page
  42. Rocklin, G. J. et al. Global analysis of protein folding using massively parallel design, synthesis, and testing. Science 357, 168–175 (2017). · DOI · Paper page
  43. Wang, J. Y. J. et al. Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains. Proc. Natl Acad. Sci. USA 120, e2214556120 (2023). · DOI
  44. Henikoff, S. & Henikoff, J. G. Amino acid substitution matrices from protein blocks. Proc. Natl Acad. Sci. USA 89, 10915–10919 (1992). · DOI · Paper page
  45. Assafa, T. E. et al. Biophysical characterization of pro-apoptotic BimBH3 peptides reveals an unexpected capacity for self-association. Structure 29, 114–124 (2021). · DOI
  46. Baek, M. et al. Efficient and accurate prediction of protein structure using RoseTTAFold2. Preprint at bioRxiv https://doi.org/10.1101/2023.05.24.542179 (2023). · DOI

Cited by

See all 239

Metadata

Authors
Vázquez Torres, S., Leung, P. J. Y., Venkatesh, P., Lutz, I. D., Hink, F., Huynh, H.-H., Becker, J., Yeh, A. H.-W., Juergens, D., Bennett, N. R., Hoofnagle, A. N., Huang, E., MacCoss, M. J., Expòsit, M., Lee, G. R., Bera, A. K., Kang, A., De La Cruz, J., Levine, P. M., Li, X., Lamb, M., Gerben, S. R., Murray, A., Heine, P., Korkmaz, E. N., Nivala, J., Stewart, L., Watson, J. L., Rogers, J. M., & Baker, D.
Venue
Nature
Published
2023-12-18
Volume
626
Issue
7998
Pages
435-442
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4389919417
Cited by
239
References
14
FWCI
17.86
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: De novo design of high-affinity binders of bioactive helical peptides. https://app.cochat.ai/papers/10.1038/s41586-023-06953-1
The paper
Vázquez Torres, S., Leung, P. J. Y., Venkatesh, P., Lutz, I. D., Hink, F., Huynh, H.-H., Becker, J., Yeh, A. H.-W., Juergens, D., Bennett, N. R., Hoofnagle, A. N., Huang, E., MacCoss, M. J., Expòsit, M., Lee, G. R., Bera, A. K., Kang, A., De La Cruz, J., Levine, P. M., . . . Baker, D. (2024). De novo design of high-affinity binders of bioactive helical peptides. Nature. https://doi.org/10.1038/s41586-023-06953-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.